← FDA Drug Approvals (Drugs@FDA)
YUVIWEL
NDA · New Drug Application · Sponsor: ASCENDIS · Approved 2026-02-27
Drug application
- FDA Application #
NDA219164- Application type
- New Drug Application
- Brand name
- YUVIWEL
- Generic name
- NAVEPEGRITIDE
- Active ingredients
- NAVEPEGRITIDE
- Dosage form
- POWDER
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- ASCENDIS
- Manufacturer
- Ascendis Pharma Endocrinology, Inc.
- First approval
- 2026-02-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown